| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.17 | 0.2 |